Allscripts (MDRX) Reports In-Line Q2 EPS

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $428 million versus the consensus estimate of $425 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c